本页面由Tiger Trade Technology Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

22.50
-1.6500-6.83%
盘后:22.500.00000.00%19:30 EDT
成交量:61.80万
成交额:1,404.32万
市值:14.52亿
市盈率:-6.75
高:24.06
开:24.05
低:22.30
收:24.15
52周最高:40.22
52周最低:20.32
股本:6,452.62万
流通股本:4,561.25万
量比:0.82
换手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-3.3325
每股收益(LYR):-0.1163
净资产收益率:-61.10%
总资产收益率:-35.87%
市净率:4.20
市盈率(LYR):-193.53

数据加载中...

2024/04/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities